Basics X4 Pharmaceuticals Inc Arsanis Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of monoclonal antibodies for the targeted immunotherapy of serious infections. IPO Date: May 13, 2022 Sector: Healthcare Industry: Biotech Market Cap: $6.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 5.16% Avg Daily Range (30 D): $0.02 | 3.39% Avg Daily Range (90 D): $0.03 | 4.07% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): .19M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 231 Avg Trade Size (Sh.) (30 D): 358 Avg Trade Size (Sh.) (90 D): 368 Institutional Trades Total Inst.Trades: 10 Avg Inst. Trade: $.93M Avg Inst. Trade (30 D): $2.54M Avg Inst. Trade (90 D): $2.54M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 5 Market Closing Trades Avg Closing Trade: $.53M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 142.9K     News May 14, 2025 @ 12:04 PM US Stock Futures Trade Higher On Wednesday: S&P 50... Source: Rishabh Mishra May 14, 2025 @ 10:49 AM US Stock Futures Trade Lower On Wednesday: S&P 500... Source: Rishabh Mishra Aug 14, 2024 @ 9:45 PM Actelis Networks Reports Q2 2024 Results: 372% Seq... Source: N/A Jul 11, 2024 @ 9:16 AM Why WD-40 Shares Are Trading Higher By Over 12%; H... Source: Avi Kapoor Jul 10, 2024 @ 8:06 PM Actelis Receives $260,000 Order for Major Mid-Atla... Source: Actelis Networks, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.22 $-.26 $-.85 Diluted EPS $-.22 $-.26 $-.85 Revenue $ .72M $ 1.06M $ 7.76M Gross Profit $ .25M $ .36M $ 4.27M Net Income / Loss $ -1.86M $ -1.8M $ -4.37M Operating Income / Loss $ -1.81M $ -1.64M $ -3.76M Cost of Revenue $ .47M $ .7M $ 3.49M Net Cash Flow $ -.84M $ -.27M $ -3.25M PE Ratio     Splits Apr 19, 2023:   1:10 Mar 14, 2019:   1:6